These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 29390604)
1. [Antipseudomonic effect of macrolides. Experience in a case of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa without response to antibiotic therapy]. Barbero JM; Arranz A; Rebollar A; Culebras A; García M; Agudo R; Pérez L; Montero E Rev Esp Quimioter; 2018 Feb; 31(1):72-74. PubMed ID: 29390604 [No Abstract] [Full Text] [Related]
2. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study. Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874 [TBL] [Abstract][Full Text] [Related]
3. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study. Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J; Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979 [TBL] [Abstract][Full Text] [Related]
4. Update on the treatment of Pseudomonas aeruginosa pneumonia. El Solh AA; Alhajhusain A J Antimicrob Chemother; 2009 Aug; 64(2):229-38. PubMed ID: 19520717 [TBL] [Abstract][Full Text] [Related]
5. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Hamer DH Am J Respir Crit Care Med; 2000 Jul; 162(1):328-30. PubMed ID: 10903263 [TBL] [Abstract][Full Text] [Related]
6. [Analysis of clinical features and outcome of nosocomial pneumonia caused by Pseudomonas aeruginosa]. Baĭgozina EA Klin Med (Mosk); 2009; 87(6):57-9. PubMed ID: 19670720 [TBL] [Abstract][Full Text] [Related]
7. Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. Furtado GH; d'Azevedo PA; Santos AF; Gales AC; Pignatari AC; Medeiros EA Int J Antimicrob Agents; 2007 Oct; 30(4):315-9. PubMed ID: 17631984 [TBL] [Abstract][Full Text] [Related]
8. [Bacterial etiology of nosocomial pneumonia and antimicrobial resistance in patients with and without antimicrobial treatment]. Weyland B; Perazzi B; García S; Rodríguez C; Vay C; Famiglietti A Rev Argent Microbiol; 2011; 43(1):18-23. PubMed ID: 21491061 [TBL] [Abstract][Full Text] [Related]
9. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy. Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262 [TBL] [Abstract][Full Text] [Related]
10. Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections. Castón JJ; De la Torre Á; Ruiz-Camps I; Sorlí ML; Torres V; Torre-Cisneros J Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956431 [TBL] [Abstract][Full Text] [Related]
11. [The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests]. Vitkauskiene A; Sakalauskas R; Dudzevicius V Medicina (Kaunas); 2003; 39(3):254-9. PubMed ID: 12695638 [TBL] [Abstract][Full Text] [Related]
12. [Importance of appropriate carbapenem use to reduce carbapenem--resistant Pseudomonas aeruginosa]. Furukawa K Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():258-64. PubMed ID: 17455627 [No Abstract] [Full Text] [Related]
13. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance. Micek ST; Wunderink RG; Kollef MH; Chen C; Rello J; Chastre J; Antonelli M; Welte T; Clair B; Ostermann H; Calbo E; Torres A; Menichetti F; Schramm GE; Menon V Crit Care; 2015 May; 19(1):219. PubMed ID: 25944081 [TBL] [Abstract][Full Text] [Related]
14. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa. Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124 [TBL] [Abstract][Full Text] [Related]
15. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994 [TBL] [Abstract][Full Text] [Related]
16. [Infections due to Legionella non-pneumophila]. Rossi G Recenti Prog Med; 2004 Jun; 95(6):316-8; quiz 344. PubMed ID: 15248416 [TBL] [Abstract][Full Text] [Related]
17. [Trends in the treatment of pneumonia]. Grassi V; Romanelli G Recenti Prog Med; 1999; 90(7-8):373-9. PubMed ID: 10429515 [No Abstract] [Full Text] [Related]
18. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Kwa AL; Loh C; Low JG; Kurup A; Tam VH Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101 [TBL] [Abstract][Full Text] [Related]
19. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience. Tennenberg AM; Davis NB; Wu SC; Kahn J Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306 [TBL] [Abstract][Full Text] [Related]